Ever come out of a London Underground station and not known where you were? Then you spot a familiar landmark like the Tower of London and suddenly you have your bearings”New research from the University of Bristol shows for the first time that global positioning systems technology (GPS) can be used to show how children as young as three find their way around.

Several Down syndrome advocacy groups have increased efforts to educate medical groups, and pregnant women and their partners about the condition since the American College of Obstetricians and Gynecologists recommended last year that all pregnant women be offered a prenatal test for the condition, the

The Government, formally announced the establishment of two new Offices to support Dr Jimmy Devins TD, Minister for Disability and Mental Health and Máire Hoctor TD, Minister for Older People. Speaking at the launch of the new Offices, the Taoiseach said “In developing the current Social Partnership Agreement, Towards 2016, a lifecycle approach was adopted which places the person at the centre of social policy development.

Osteopaths from around the world will gather today in London to mark the 10th anniversary of the opening of the UK Statutory Register for Osteopaths at a reception held in the presence of HRH The Prince of Wales.

Centene Corporation (NYSE: CNC) announced an initiative to promote provider participation in the national Back Pain Recognition Program (BPRP) developed by the National Committee for Quality Assurance (NCQA). The BPRP was launched in January 2007 to recognize healthcare providers who deliver top-quality care to patients with low back pain. One in nine Americans suffer from back pain each year; related treatment costs total approximately $91 billion annually.

Compugen Ltd. (NASDAQ:CGEN) announced the results from initial in-vivo validation studies of CGEN-855A and CGEN-855B, two novel peptide agonists of the FPRL1 G-protein coupled receptor (GPCR), which may serve as anti-inflammatory and cardio-protective drug candidates. CGEN-855A and CGEN-855B were discovered using the Company’s previously announced GPCR ligand discovery platform.

A protein has been found that influences the response of the heart to a lack of oxygen and blood flow, such as occurs during a heart attack, a team of Yale School of Medicine researchers report in Nature.This finding may present a new therapeutic approach to treating loss of blood flow and oxygen to the heart.

Mobile Aspects announced that the Center for Congenital and Structural Heart Disease (CCSHD) at Rush University Medical Center, Chicago, has agreed to install iRISupply”, a clinical resource management system that manages medical devices and supplies through radio frequency identification (RFID) technology.

Medtronic, Inc. (NYSE: MDT) announced the FDA approval of a new physician-use continuous glucose monitoring (CGM) system, the CGMS® iPro” Recorder. Physicians send patients home with the CGMS iPro Recorder to uncover patterns and potential problems that often go undetected with today’s standard glucose measurements like finger stick meters and HbA1c tests. The new CGMS iPro Recorder is smaller, lighter in weight and less time consuming to use than previous CGMS recorders.

dermaCM, announces successful findings of a double blind human taste test using proprietary nanolipidic particles (NLP) to mask the taste of sodium chloride in distilled water preparations. Taste-masking nanotechnology can be used to mask unpleasant tastes in beverage, pharmaceuticals and nutricuetical preparations, vastly improving consumer acceptance, patient compliance and user satisfaction.